课题基金 / 基金详情

Loss of Vitamin A Metabolism in Ovarian Oncogenesis

Loss of Vitamin A Metabolism in Ovarian Oncogenesis
卵巢肿瘤发生过程中维生素 A 代谢的丧失
批准号:
7078581
负责人:
THOMAS C. HAMILTON
金额:
$29.33万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-06-15 至 2010-04-30

项目摘要

项目成果

THOMAS C. HAMILTON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): We recently reported a consistent loss in expression of a protein important for vitamin A homeostasis, cellular retinol-binding protein 1 (CRBP1), in a rat model of ovarian cancer, human ovarian cancer cell lines and in microdissected tumor tissues. This loss was also found in various precursor lesions in prophylactic oophorectomies from women at high risk for breast and ovarian cancer. Moreover, complete loss of vitamin A metabolism was discovered through HPLC analysis in ovarian cancer cells relative to normal ovarian surface epithelium. Such alterations have also been shown in breast cancer. Based on these observations, we hypothesize that concomitant losses of CRBP1 expression and vitamin A metabolism contribute to the etiology of ovarian carcinoma by altering redox and/or differentiation capacity of normal ovarian cells, thus leading to cellular damage conducive to transformation. Our hypothesis will be tested by implementation of the following Specific Aims: 1) Analyze the impact of altered CRBP1 expression and vitamin A homeostasis on ovarian histology and the initiation of ovarian cancer in genetically engineered mice, 2) Determine the impact of CRBP1 expression alteration on the cancer phenotype and ovarian surface epithelial cell transformation, and 3) Determine the impact of altered CRBP1 expression and vitamin A homeostasis on the redox and differentiation status of the ovarian epithelium. Strategies for addressing the specific aims will focus on in vitro and in vivo evaluation of normal and CRBP1-null mice and then ovarian surface epithelial (MOSE) cells, and CRBP1-inducible human ovarian cell lines. Hopefully, these endeavors will result in a better understanding of ovarian cancer development and progression and provide a basis for more effective prevention of this frequently fatal disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Therapeutic Micro RNA Strategies for Ovarian Cancer
  • 批准号:
    7727493
  • 项目类别:
  • 资助金额:
    $42.31万
  • 财政年份:
    2009
  • 负责人:
    THOMAS C. HAMILTON
  • 依托单位:
HHMT 10th Biennial International Forum on Ovarian Cancer
  • 批准号:
    6838060
  • 项目类别:
  • 资助金额:
    $1.0万
  • 财政年份:
    2005
  • 负责人:
    THOMAS C. HAMILTON
  • 依托单位:
Loss of Vitamin A Metabolism in Ovarian Oncogenesis
  • 批准号:
    7413334
  • 项目类别:
  • 资助金额:
    $28.48万
  • 财政年份:
    2005
  • 负责人:
    THOMAS C. HAMILTON
  • 依托单位:
Loss of Vitamin A Metabolism in Ovarian Oncogenesis
  • 批准号:
    7230451
  • 项目类别:
  • 资助金额:
    $28.48万
  • 财政年份:
    2005
  • 负责人:
    THOMAS C. HAMILTON
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
  • 批准号:
    31970691
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2019
  • 负责人:
    张胜萍
  • 依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
  • 批准号:
    31900527
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2019
  • 负责人:
    孙磊
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位: